Ovarian PRP is a newly developing technique in ovarian rejuvenation offered to women who have suffered early menopause such as under 38 years who are either perimenopausal or postmenopausal for less than 5 years of age or women with unknown reasons for low egg reserves in their ovaries. It is a desirable option for many couples as there is no need to go for donor eggs and the child carries their own genetic material.
The procedure includes injections of growth factors derived from the patient’s own blood and is called Platelet Rich Plasma(PRP) therapy and is an safe option to be tried before going for egg donors.
What Is Ovarian PRP Therapy?
Platelet‑Rich Plasma (PRP) is a concentrated fraction of blood rich in platelets, growth factors, and bioactive proteins.
These components play well‑established roles in tissue healing, regeneration, and cellular signalling in many medical applications. In ovarian rejuvenation, PRP is used because:
- Platelets carry growth factors that can stimulate cell proliferation and repair.
- These growth factors may help improve the microenvironment of ovarian tissue.
When injected into the ovary, they may encourage dormant follicles to grow and support folliculogenesis.
The procedure usually involves drawing a small amount of the patient’s blood, processing it in a centrifuge to isolate the PRP, and then injecting this PRP directly into the ovaries using ultrasound guidance — a process similar to egg retrieval in IVF but without retrieving eggs.
Because the therapy uses the patient’s own blood, the risk of allergic reaction or immune consequence is extremely low, and there is no synthetic material used.
Who Can Benefit?
Ovarian PRP may be offered to women who:
- Are under 38 years of age but experiencing early or premature menopause.
- Have low ovarian reserve or unexplained diminished egg quantity.
- Are perimenopausal or postmenopausal for less than five years.
In these groups, PRP may be considered especially when conventional treatments have had limited success or when preserving natural genetic parenthood is a priority.
How Does It Work?
Once prepared, the PRP — a concentrate of platelets and growth factors — is injected directly into ovarian tissue under imaging guidance. The rationale behind this approach is that growth factors:
- Stimulate cellular repair and regeneration.
- Activate dormant or resting follicles that may otherwise remain inactive.
- Improve local blood flow and tissue health to support follicle maturation.
Although the exact mechanisms are still under investigation in reproductive science, early clinical reports and research suggest that PRP may have a positive influence on ovarian reserve markers and function.
Benefits and Expectation. Potentially, Ovarian PRP therapy may help to:
- Increase ovarian reserve indicators such as antral follicle count (AFC) and anti‑Müllerian hormone (AMH).
- Enhance response in assisted reproductive techniques such as IVF by providing more responsive ovarian tissue.
- Support natural ovulation or improved hormonal balance in some cases.
Importantly, while outcomes in some patients are promising, PRP is still considered experimental and not universally guaranteed. Results vary, and success depends on individual ovarian health, age, and other fertility factors.
Safety and Considerations
PRP therapy is generally well‑tolerated and carries a low risk since it uses the patient’s own blood. However:
- The procedure may require sedation or local anesthesia.
- Mild discomfort or transient cramping may occur post‑procedure.
- Because PRP for ovarian rejuvenation is still emerging, long‑term evidence is limited.
Patients are encouraged to discuss candidly with fertility specialists to understand personal suitability, realistic success expectations, and integration into broader fertility plans.
Conclusion
Ovarian PRP represents a hopeful option for women facing diminished ovarian reserve or early menopause who wish to explore possibilities before donor egg options. With ongoing research and clinical experience, it has the potential to become a part of individualized fertility strategies.
